If you have kidney disease, your body may not be able to easily clear magnesium, which can build up and lead to side effects such as weakness, low blood pressure, and heart rhythm problems
This serious adverse effect requires urgent assessment and typically necessitates discontinuation of the medication
At baseline, most initiators began treatment with liraglutide (61.9%), followed by semaglutide (22.5%), dulaglutide (11.7%), exenatide (2.4%) and lixisenatide (1.5%)
Because existing hair follicles must complete their current cycle, enter anagen phase, and produce a new, thicker hair shaftyou cannot accelerate the biological clock here
This condition has also been associated with Ozempic and other GLP-1s (though rare)
Ongoing Phase 3 trials are expected to provide more robust safety information